AETHLON MEDICAL, INC. Proceeds from Collection of Notes Receivable
AETHLON MEDICAL, INC. (AEMD) reported Proceeds from Collection of Notes Receivable of $0 for the 12-month period ending 2013-03-31, per its 10-K filed 2013-07-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromCollectionOfNotesReceivable · last filed 2013-07-15
- AETHLON MEDICAL, INC. proceeds from collection of notes receivable for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- AETHLON MEDICAL, INC. proceeds from collection of notes receivable for the quarter ending 2011-12-31 was $0.00.
- AETHLON MEDICAL, INC. proceeds from collection of notes receivable for the quarter ending 2011-09-30 was $0.00.
- AETHLON MEDICAL, INC. proceeds from collection of notes receivable for the quarter ending 2011-06-30 was $200.00K.
- AETHLON MEDICAL, INC. proceeds from collection of notes receivable for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- AETHLON MEDICAL, INC. proceeds from collection of notes receivable for fiscal 2012 was $200.00K, a 60.00% decline from fiscal 2011.
- AETHLON MEDICAL, INC. proceeds from collection of notes receivable for fiscal 2011 was $500.00K.
| Period end | Proceeds from Collection of Notes Receivable 3 month | Proceeds from Collection of Notes Receivable 6 month | Proceeds from Collection of Notes Receivable 9 month | Proceeds from Collection of Notes Receivable 12 month | Proceeds from Collection of Notes Receivable 329 month | Proceeds from Collection of Notes Receivable 332 month |
|---|---|---|---|---|---|---|
| 2013-03-31 | $0.00 10-K · filed 2013-07-15 | |||||
| 2012-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-15 | $0.00 derived: sum of 2 quarters · filed 2013-07-15 | $0.00 derived: sum of 3 quarters · filed 2013-07-15 | $200.00K 10-K · filed 2013-07-15 | ||
| 2011-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-12 | $0.00 derived: sum of 2 quarters · filed 2013-02-12 | $200.00K 10-Q · filed 2013-02-12 | $400.00K derived: sum of 4 quarters · filed 2013-02-12 | ||
| 2011-09-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-11-13 | $200.00K 10-Q · filed 2012-11-13 | $400.00K derived: sum of 3 quarters · filed 2012-11-13 | $700.00K 10-Q · filed 2011-11-18 | ||
| 2011-06-30 | $200.00K 10-Q/A · filed 2012-08-28 | $400.00K derived: sum of 2 quarters · filed 2012-08-28 | $700.00K 10-Q/A · filed 2011-08-22 | |||
| 2011-03-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-29 | $500.00K 10-K · filed 2012-06-29 | ||||
| 2010-12-31 | $300.00K 10-Q · filed 2012-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |